Die OptiMed-Heiminfusionstherapie hält die Patienten mit ihrer Betreuung auf Kurs und reduziert gleichzeitig das Risiko für COVID-19
National Home Infusion Association gibt Empfehlungen zur Förderung der Patientensicherheit und Kostendämpfung heraus
KALAMAZOO, Mich., April 6, 2020 (Newswire.com) - As COVID-19 cases spread rapidly across the U.S., there is a new call by the National Home Infusion Association (NHIA) to treat patients needing specialty infusions in their homes offered by OptiMed, a home infusion pharmacy with national capabilities.
Die NHIA, die eine führende Stimme zur häuslichen Infusionstherapie ist, gab am 30. März eine Erklärung ab, in der sie sich für die Verwendung der häuslichen Infusion aussprach, um den Patienten zu helfen, mit ihrer Therapie auf Kurs zu bleiben und gleichzeitig das Risiko der Exposition gegenüber COVID-19 zu verringern.
"Home infusion pharmacies have safely and effectively treated patients in the home for decades," the statement reads. "While the demand for these services by commercial payers has been largely focused on the cost-effectiveness of home infusion, this site of care has the additional benefits of freeing up hospital resources to treat those most in need and limiting exposure to pathogens. This makes home infusion a powerful tool in the fight against COVID-19."
Andy Reeves, CEO of Michigan-based OptiMed, said there’s already been an increase in transitioning patients to home infusion therapy in the past two weeks because of COVID-19. He said home infusion is not only safer and more convenient but typically is less costly.
Bei der häuslichen Infusion wird die Infusion des Patienten von einer Krankenschwester in der häuslichen Umgebung vorgenommen. Die Therapieanbieter koordinieren die Patientenversorgung durch ein Team hochqualifizierter Fachleute, zu denen ein Infusionsapotheker, Infusionsschwestern, Pflegemanager und der verschreibende Anbieter gehören, wodurch sichergestellt wird, dass der Patient eine optimale Behandlung erhält.
“Our expertise has always been delivering patient-centered care that is safe, timely, clinically sound, and cost-effective,” said Reeves. “During COVID-19, we are committed to providing an impactful solution for patients, payers, and health systems through our ability to expeditiously transition patients on specialty infusions to receive care safely in their homes.”
About OptiMed: OptiMed Health Partners, headquartered in Kalamazoo, Michigan, is an independently owned and operated national healthcare organization. With over 25 years of experience, OptiMed leverages personalized attention to detail to deliver customized solutions that optimize patient outcomes while partnering with other healthcare organizations to usher in a new standard of excellence. To learn more about OptiMed’s innovative and personalized care, visit OptiMedHP.com.
If you or someone you know is receiving infused or injected therapies, please contact OptiMed at 877-232-2857 to discuss treatment options and the benefits of in-home services.